Splenectomy is a powerful therapeutic procedure in a wide variety of medical disorders provided that it is not undertaken lightly and the risks are weighed against the potential benefits in each individual case. Most of this risk seems to be due to the underlying splenectomy indication and not to splenectomy alone. There has been an increased tendency in recent years towards splenic preservation to prevent not only the risk of subsequent overwhelming post-splenectomy infection (OPSI) but the long term risk of cardiovascular complications. As there is no condition that can be cured by splenectomy, this paper reviewed the rationale behind the indications for, and the associated risks. Method: Electronic searches of the medline (PubMed) database, Cochrane library, and science citation index were performed to identify original published studies on splenectomy. Relevant articles were searched from relevant chapters in specialized texts and all included.
Introduction
Since the first deliberate removal of a diseased spleen by Quittenbaum in 1826 splenectomy has become a well established surgical procedure. 1 A spleenless existence was considered to be quite safe as the spleen was considered unnecessary for life until 1952 when King and Schumacher drew attention to the risk of overwhelming post splenectomy infection (OPSI). 2 Since that time enthusiasm for splenectomy has diminished. The spleen clearly serves extremely important haematological and immunological functions. As part of the reticulo-endothelial system and by receiving 25% of the cardiac output, it plays a major part in the immediate immunological response to blood-borne antigens akin to the phagocytic role of 'Kupffer' cells of the liver in the portal circulation. 3 As the spleen is responsible for making antibodies and removing bacteria, aged, antibody-coated and damaged blood cells, those without a spleen have an impaired immune system. 4, 5 Because of this, splenectomized patients have a more difficult time recovering from pneumonia, meningitis, haemophilus influenzae (Hib) flu, sepsis, nosocomial infections, babesiosis (a tick-borne disease), malaria and other parasitic diseases and gram-negative bacterial diseases from animal bites. 6e8 Although the liver can perform this function in the absence of the spleen, higher levels of specific antibody and an intact complement system are probably required. 5 As the spleen also destroys and modifies abnormal red cells, sequesters 30e40% of the circulating platelet pool and plays a role in the regulation of plasma volume, the spleen is usually involved in haematological disorders. 9, 10 Infact, the most frequent medical indication for splenectomy is a haematologic disorder. 11 Overwhelming bacterial sepsis as a complication in persons with asplenia, is now infrequent because of pneumococcal vaccinations, prophylactic penicillin, and prompt medical attention at the first sign of fever. 12, 13 However, during the past decade evidence has emerged that an increased risk of thrombosis, both venous and arterial, may result from splenectomy. 14 The increased risk of venous thromboembolism is particularly within the splenoportal system. This complication has been described in diverse asplenic states including hereditary spherocytosis (HS), thalassaemia, other haemolytic anaemias, and trauma. 14e16 In thalassaemia and sickle cell disease, another vascular complication, pulmonary hypertension (PH), has also been described following splenectomy, with some studies reporting PH prevalence as high as 75%. 17, 18 Splenectomy may have an impact on immunological function but there is no increased cancer risk among patients splenectomized because of trauma. 1 A recent study revealed an increased risk for some specific cancer sites in patients who underwent splenectomy for non-traumatic reasons, although the effect of treatments for the underlying disease and lifestyle habits such as cigarette smoking could not be ruled out in explaining these excess risks. 19 In most institutions, trauma is the primary indication for splenectomy, although it is becoming less common in recent years with more non-operative management of splenic injury. 20 
Role of the spleen in haematological disorders
The normal spleen may serve as a major site of destruction of abnormal cellular elements of the blood, e.g. in hereditary spherocytosis, autoimmune anaemia, neutropenia and thrombocytopaenia. In the last two situations the spleen serves as the major site of antibody production. The abnormal or diseased spleen gives rise to two major syndromes; hypersplenism and symptomatic splenomegaly. Hypersplenism refers to anaemia, neutropenia and/ or thrombocytopaenia arising singly or in combination as a direct result of enlargement from whatever cause of the spleen. The diagnosis is confirmed retrospectively by correction of the cytopenia after splenectomy. 1, 9 Hypersplenic thrombocytopaenia results largely from increased platelet pooling within the spleen. As many as 98% of total blood platelets may be sequestered in an enlarged spleen and there is some evidence that splenomegaly shortens platelet survival. 10, 11 The neutropenia of hypersplenism probably results purely from an increased margination pool of granulocytes in the vessels of the enlarged spleen. Hypersplenism often also occurs in conditions that result in bone marrow failure. Extramedullary haematopoiesis may occur in the inherited haemolytic anaemias which soon leads to hepatosplenomegaly and bone expansion. 9 Symptomatic splenomegaly is most commonly encountered in lymphoproliferative and myeloproliferative disorders. Increased metabolism may give rise to weight loss, fever, hyperhidrosis, and vague left upper quadrant pain associated with reduced blood flow and resulting infarction. 21 3. Indications for splenectomy
Absolute indications
The absolute indications include ruptured spleen, treatment of splenic cysts and abscesses as all organ is usually affected, and tumour resection involving adjacent organs (Table 1) . 1, 9, 22 It can be very difficult to decide whether a patient needs an emergency splenectomy after trauma, particularly when the patient is haemodynamically stable and has minimal signs of abdominal injury. Special investigations do not provide absolute answers and the risk of delayed and unnecessary laparotomies will remain. Focused assessment with sonography for trauma (FAST) is an excellent investigation for haemoperitoneum in blunt trauma with a sensitivity of 88%. 23 An emergency laparotomy is indicated for a positive FAST in the shocked patient. A CT scan with intravenous contrast is the single most useful investigation in the haemodynamically stable patient as it can assess for intraperitoneal fluid, solid organ injury and retroperitoneal haematoma. Repeated scanning (ultrasound or CT) have been found particularly helpful in assessing splenic bleeding or haematoma especially if patient is slowly dropping her haemoglobin. 24e26 Laparoscopy has no role in trauma ( Table 2) . 24 Because the risks of uncontrolled haemorrhage and major transfusion are greater than OPSI, splenectomy should be performed without delay if splenic bleeding is not controlled during laparotomy. However, if a splenic tear is found which is not actively bleeding with adherent clot it should be left undisturbed. 22, 24, 25 The growing awareness of possible long term complications and the increasing reports of the failure of prophylactic measures have led increasingly to the use of partial splenectomy with retention of some splenic tissue wherever possible, especially in children following splenic trauma. 26, 27 Splenic salvage techniques are more feasible in children because of the greater ratio of splenic capsular tissue to pulp tissue. They include partial splenectomy, splenorrhaphy, ligation of segmental vessels and capsular repair. 1, 28 Partial splenectomy may be considered with deep tears to the hilum but should only be performed if there are no other life-threatening injuries as it is a complicated surgery. 26, 28 Thus, the conservative thing to do in splenic trauma is splenectomy and it is prudent to err on the side of splenectomy in all major multiple trauma and military cases. 24, 25 Superficial splenic tears may be sutured using absorbable mattress sutures buttressed with Surgicel, teflon or omentum. Ligation of segmental vessels at the splenic hilum may be useful in obtaining haemostasis from a splenic tear. Topical haemostatic agents e.g. microfibrillar collagen (fibrin glue) and absorbable envelopes have also been used successfully to preserve the spleen. 1, 28 Splenosis and auto transplantation may have some minor immunological function but have not been shown to be effective in preventing overwhelming post splenectomy infection. 27 It seems likely that the normal splenic vasculature is crucial for maximum protection. Indeed there has been some uncertainty of the level of splenic function achieved by partial splenectomy especially if more than half the spleen is removed or the splenic artery has to be tied as the patient probably loses most immunological benefit. 3 It would be prudent to institute similar prophylactic measures in these patients to prevent infection as for asplenic individuals. 3.1.1. Non-operative management The current management of trauma is usually dictated by the age of the patient, the experience of the institution, the individual surgeon and the type of trauma.
1 Non-operative management of splenic trauma has also become an option. 20e40% of laparotomies performed for haemoperitoneum reveal that bleeding has stopped and that the injuries do not require surgery. 20 The practice began in the 1970's in paediatric patients and was highly successful with an average failure rate of 10.8%. The majority of failures occurring in the first 24 h. 30 In an isolated splenic trauma in a haemodynamically stable patient with no evidence of continuous bleeding, regular observations and haemoglobin measurements may be suitable for at least 10days. 1, 24 The patient should be counselled on the risk of delayed rupture after a period of several days (or even of 2e3 weeks). This equally dangerous condition may arise when the damage to the spleen is less severe. The laceration may become temporarily sealed eoff by omentum or by blood clot or the bleeding may at first be confined within the capsule of the organ (subcapsular). 22 A patient under non-operative management for blunt abdominal injuries should be admitted initially to ICU/HDU for at least 48e72 h for close monitoring of vital signs, repeated clinical examinations and followup investigations as indicated. But splenectomy or splenic repair is warranted in an unstable patient despite resuscitation. 31 Arteriography with embolisation are increasingly important adjuncts to nonoperative management of splenic injuries.
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Relative indications for splenectomy
The relative indications for splenectomy includes hypersplenism, symptomatic splenomegaly and destruction of abnormal blood cells in the spleen. 1, 9 Splenectomy is performed in patients having haemolytic anaemia (e.g., hereditary spherocytosis [HS], and autoimmune haemolytic anaemia) because the intrinsically abnormal or antibody-coated red blood cells are prematurely destroyed by splenic macrophages (Table 3) . Because splenectomy can ameliorate the underlying anaemia, it is often considered the treatment of choice although none of these conditions can be cured by splenectomy. Two facts must be established before splenectomy in haematological patients. Firstly, the spleen must be shown to be the site of excessive destruction of red cells, by examination of the bone marrow and of peripheral blood and isotope studies to illustrate excessive uptake in the spleen. Secondly, the bone marrow must be shown capable of producing sufficient new cells to correct the cytopenia in the absence of the spleen. Otherwise, no reversal of cytopenia is possible and the patient's condition will continue to deteriorate. 1 Where splenectomy is being carried out for haematological disorders a careful search should be also be made for accessory spleens. 9 The long-term thromboembolic risk which is higher in haematological disorders associated with ongoing haemolysis, particularly thalassaemia intermedia, has led to a more non-operative approach.
14 In comparison, patients with ITP appear to be at lower risk of adverse effects of splenectomy, which maintains its place as the potentially most curative and safe second-line treatment. However, a splenectomy-sparing approach is also emerging for ITP, and recent guidelines recommend that this procedure is deferred until 12 months following ITP diagnosis, to allow sufficient time for possible remission. 
Red cell disorders
Red cell disorders including hereditary spherocytosis, elliptocytosis, pyruvate kinase deficiency present with severe anaemia, haemolytic crisis, chronic leg ulcers and sometimes pigment gallstones in the former. 9 Splenectomy reliably corrects the clinical picture with very low mortality and morbidity, but is usually delayed beyond five years of age to reduce the risk of overwhelming post splenectomy infection. 33 Cholecystectomy is done if there is associated gallstone disease.
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Thalassaemia syndromes
Thalassaemia syndromes are inherited disorders in which the rate of synthesis of one or more globin chain are reduced resulting in defective erythropoiesis, haemolysis and consequent marked splenomegaly and hypersplenism with increasing transfusion requirements and severe iron overload. Splenectomy reduces the need for blood transfusion requirements and it is usually done before six and eight years. 9, 14 As the risk of thrombotic complications and sequelae (venous thrombosis and pulmonary hypertension) arising after an average interval of about 8 years is particularly prominent in patients who underwent splenectomy, the current thrust in prevention is to avoid splenectomy, even if this choice entails a greater need of red cell transfusion and iron chelation. It has also been shown that in splenectomized patients with thalassaemia intermedia who developed thrombosis, the platelet count was much higher than in those who did not in spite of being asplenic. Although it remains to be established whether or not the high platelet count is the cause of thrombosis, it is reasonable to recommend aspirin (100e300 mg daily) to patients at higher risk because of a high platelet count. 
Homozygous sickle cell disease
Homozygous sickle cell disease is characterized by chronic haemolysis and recurrent episodes of tissue infarction. Repeated splenic infarction usually causes 'autosplenectomy' before adulthood, but splenectomy may occasionally be required for persistent hypersplenism. 8 Acute splenic sequestration is the second most common cause of death in the first decade of life and has a high rate of recurrence. 34 Splenectomy may thus be indicated for infants with recurrent acute splenic sequestration characterized by rapidly falling haemoglobin due to pooling of blood in an acutely enlarged spleen. 35 Patients who have a severe episode of acute splenic sequestration and are below age 2 years should be placed in a chronic transfusion programme to keep HbS level below 30% until a splenectomy is performed at age 2 years. 36 Splenectomy, if full, will prevent further sequestration and if partial, may reduce the Table 3 Relative indications and benefits of splenectomy. recurrence of acute splenic sequestration crises. However, there is a lack of evidence from trials showing that splenectomy improves survival and decreases morbidity in people with sickle cell disease. There is a need for a well-designed, adequately-powered, randomized controlled trial to assess the benefits and risks of splenectomy compared to transfusion programmes, as a means of improving survival and decreasing mortality from acute splenic sequestration in people with sickle cell disease. 35 Infection is still the commonest cause of death irrespective of splenectomy. 
Platelet disorders
Splenectomies have been used to treat immune thrombocytopenic purpura (ITP) since 1913. 9, 37 However its long-term safety is not well elucidated. 32, 38, 39 In ITP the spleen plays a dual role, serving as the main site of both antiplatelet antibody production and destruction of antibody-coated platelets. Therefore removing the spleen may reduce the amount of anti-platelet antibodies in addition to removing the antibody-coated platelets. While a splenectomy may raise the platelet count, it does not eliminate ITP since the antibody-coated platelets remain in circulation. 38 Although the spleen is often the major site of antibody-coated platelet destruction, platelets may also be removed from circulation by the liver, by a combination of the spleen and liver, or within the blood stream. Therefore, splenectomies are not always successful in raising the platelet count and may fail over time, prompting a return of low platelets. The sequestration site is a good predictive element in the short-term efficacy of splenectomy with a platelet count exceeding 100 Â 10 9 /l if splenic sequestration occurred alone but much less with mixed and least with hepatic sequestration. 38, 39 Splenectomy is indicated following failed response to steroid treatment and about 70% achieve an immediate and sustained platelet response after splenectomy but 7% achieve a delayed response. All accessory spleens must be sought and removed. If the platelet count is less than 70,000 pre-operatively then fresh platelets are given once the splenic artery is clamped otherwise they are "consumed" in a few minutes by the unclamped spleen. For those who do respond, 30e35% relapse over time. 1, 9, 32 Previous response to corticosteroids or other treatments are not very good predictors of splenectomy success. Age under 40 years is the only positive predictive factor for the long term response to splenectomy in ITP. 40 Researchers suggest that a raised serum biomarker protein haptoglobin (Hp) that binds to free haemoglobin released by red blood cells predicts long-term response to splenectomy for ITP in about 80% of cases. 41 In a small proportion of the splenectomized ITP population a second surgery is occasionally required to remove an (extra)accessory spleen if the patient has relapsed following a successful first surgery. The first meta-analysis of randomized clinical trials and observational studies on rituximab has shown its effectiveness as a splenectomy-avoiding option in adult chronic ITP. Age was also the most relevant effect and rituximab should be used earlier in non-splenectomised patients. 42 Laparoscopic splenectomy (LS) is preferred when possible in ITP as these patients are on steroids with risk of infection and poor wound healing. 43 A recent retrospective study demonstrated a 6.4%
conversion rate to open surgery which was mostly due to larger spleens. 44 A previous comparative study on operations on massive splenomegaly had demonstrated a 6.6% conversion rate to open and despite a significant longer operating time, the post operative recovery following laparoscopic splenectomy was smoother with lower morbidity and shorter post operative hospital stay. 45 
Lymphoproliferative disease (Hodgkin's/Non-Hodgkin's lymphoma)
Clinical studies have not demonstrated an improvement in prognosis following splenectomy and the indications are diminishing with the effectiveness of CT scanning in staging Hodgkin's disease and the responsiveness to chemotherapy. 21 Splenectomy, may on occasion be required to make a positive diagnosis because of the suspicion of an underlying lymphoma, reticulosis or infiltrative condition. Several investigations have suggested that splenectomy in patients with Hodgkin's disease increases the risk for secondary leukaemia independent of treatment. 19 
Myelofibrosis
Splenectomy for myelofibrosis does not prolong survival but may be indicated as a palliative measure for symptomatic splenomegaly. 1 The proliferative process affect the bone marrow, liver, spleen and lymph nodes. The spleen may be grossly enlarged and portal hypertension may develop. Early post operative morbidity and mortality are very high due to impaired haemostasis, large spleen and the usually elderly patients in poor general condition. 46 Splenectomy should be performed very occasionally for severe pain and hypersplenism (low haemoglobin and low white blood cell count) at an earlier stage of the disease. Otherwise conservative treatment with blood transfusion for anaemia may give better palliation. 47 
Malaria
Comparison of infected patients with or without spleens supports the idea that the spleen removes dead or damaged intracellular parasites and returns intact erythrocytes into the blood stream. 7, 48 Splenectomy is therefore not indicated for symptomatic splenomegaly unless the spleen has ruptured. 22 
Congestive splenomegaly
Congestive splenomegaly from intrahepatic or extrahepatic portal venous obstruction is most commonly caused by cirrhosis. Splenectomy is reserved for the rare patient with severe residual thrombocytopaenia after portasystemic shunting. 49 If splenic venous thrombosis is the underlying cause then splenectomy is the treatment of choice.
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3.2.9. Felty's syndrome Felty's syndrome is characterized by rheumatoid arthritis and splenic neutropenia, commonly associated with anaemia and chronic leg ulcers. Many immunological and rheumatological disorders are associated with impairment of the spleen's phagocytic and immunological functions. Transient functional hyposplenism may also occur during therapy with corticosteroids and after pharmaceutical reticulo-endothelial blockade with intravenous IgG or anti-D immunoglobulin. Splenectomy controls the neutropenia in the majority of patients with serious or recurrent infections or non healing leg ulcers. 50 
Hazards of splenectomy
The complications of splenectomy may be conveniently divided into acute, short and long term as shown in Table 4 .
Haemorrhage
During operation bleeding can occur from divided adhesions, a tear in the splenic capsule, from the splenic vessels or short gastrics or from the tail of the pancreas. After operation, reactive haemorrhage may occur from the small vessels in the posterior abdominal wall and diaphragm. Therefore haemostasis must be meticulous to prevent the development of a large haematoma, which may become infected. The operative mortality varies between 3 and 15%, depending upon the physical state of the patient and the condition for which the operation was performed. 1 The mortality is particularly high (30%) following splenectomy for myeloproliferative disorders (i.e. myelofibrosis, chronic granulocytic leukaemia). 47 The high morbidity and mortality are as a result of bleeding. The platelets in myeloproliferative disorders are a part of the malignant population and defects in function have been reported. Therefore the assessment of platelet function or bleeding time should be performed before splenectomy in this group and the possibility of platelet transfusion despite a normal platelet count should be considered. 46, 47 Patients over 65 have a higher complication and fatality rate. 
Thromboembolic
Thromboembolic complications following splenectomy for haematological diseases occur in up to 10% of patients and may range from portal vein thrombosis to pulmonary embolism and deep vein thrombosis. 51 Given the increased platelet count postsplenectomy which is maximal by the 10th day, deep vein thrombosis (DVT) or pulmonary embolism has also to be considered as a cause of post operative pyrexia. Both DVT and small pulmonary embolism may otherwise be silent although they may of course be the harbinger of a massive pulmonary embolism. 52 Splenic/portal vein thrombosis is an alarming complication of splenectomy presenting with fever and abdominal pain and a mortality of w10%.
51e 54 The median time from splenectomy to symptomatic splenic vein thrombosis is 8e12 days. 52 Fatal outcomes have been reported 7e 35 days after splenectomy for autoimmune haemolytic anaemia, immune thrombocytopaenia and indolent lymphoma respectively. 53 Retrospective studies have shown the incidence of symptomatic splenic/portal vein thrombosis varying from 0.7% to 8%.
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The overall risk addressed in prospective and retrospective randomized or non-randomized trials is 3.3%. Risk factors are big spleens (i.e. myeloproloferative disorders and hereditary haemolytic anaemia) whereas risk is low in autoimmune thrombocytopaenia and trauma. The incidence is approximately the same in laparoscopic and open splenectomy. 54 A high index of suspicion, early diagnosis by contrast eenhanced computed tomography and prompt anticoagulation are key to successful outcome. 54 Generally prior to splenectomy, correction of preoperative coagulation abnormalities, intensive post operative chest physiotherapy and antiplatelet therapy with low dose aspirin if platelet counts rise postoperatively above 800 Â 10 9 /l all make surgery safer. 1 There exist no standard recommendations for the duration and intensity of prophylactic anticoagulation which usually follow local institutional protocols. Post operative antithrombotic prophylaxis ranged from no prophylaxis to heparin for seven days or longer. 53 Treatment of symptomatic splenic vein thrombosis with heparin and warfarin leads to complete resolution of thrombosis in 67%, to partial resolution in 13%, but persistent occlusion, portal hypertension or cavernoma occurred in 20%. 54 The long-term outcome of treatment failures is unknown. Well-designed randomized studies on the prophylaxis of venous thromboembolism after splenectomy are urgently needed.
Subphrenic abscess
Subphrenic abscess is not common. It may arise from an infected haematoma or infection following injury of the adjacent stomach or colon. Patients with autoimmune disorders e.g. immune thrombocytopenic purpura (ITP) who have been on steroids have a high frequency of subphrenic abscesses and are mostly aborted by a course of antibiotics. 47 
Chest infection
The patients with lymphoproliferative malignancies e.g. Hodgkin's lymphoma, chronic lymphocytic leukaemia have a high morbidity from infective complications especially bronchitis and pneumonia. 6, 21, 47 By being minimally invasive with less pain, the laparoscopic technique as opposed to open may decrease the risk of post operative chest infections due to atelectasis and sputum retention. 45 
OPSI
The major long-term risk of splenectomy is overwhelming postsplenectomy infection (OPSI).
2 Post trauma, the life-time risk of OPSI is 0.1e0.5% and has a mortality of up to 50%. 12 The risk of infection is life long as cases of fulminant infection have been reported more than 20 years post splenectomy and is greater with encapsulated organisms -streptococcus pneumonia, nessieria meningitides, and H influenza. 29, 55 Pneumococcal infection is most common and carries a mortality rate of up to 60%. 2, 12 Infection with H influenza type B, whilst much less common is nonetheless significant, particularly in children. The risk of OPSI is greatest during the first 3-years post splenectomy; greater in children especially under 5 years and who have had splenectomy for trauma (>10% excess risk) than adults (<1%). 2, 29, 56 The risk of infection with encapsulated organisms is increased in immunosuppressed or immunodeficient individuals (e.g. HIV, myeloma, leukaemia).
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Prevention of overwhelming post splenectomy infection (OPSI)
Overwhelming infection in hyposplenic or asplenic patients thus remains an area of concern. 2, 12 This may include infection by unusual serotypes not included in the vaccinations. 62, 63 All splenectomized patients greater than 2 yrs old and those with functional hyposplenism should receive pneumococcal vaccination, haemophilus influenzae type b conjugate vaccine and meningococcal conjugate vaccine at least 2 weeks before splenectomy in order to ensure an optimal antibody response. Immunisation should be administered following emergency splenectomy, but the effect is not as good, although still better than not being given. 29 Time frames may be different for those with immunosuppressive, sickle-cell disorders and on immune suppressing therapies. 29 Because of waning immunity timing of revaccination may be determined by levels of protective antibody (Table 5) . 
Discussion
Regardless of indication, the adjusted short-and long-term risk of death for splenectomised patients was higher than the general population. Within 90 days post-splenectomy, the adjusted relative risk (RR) for death was 33.6%. 59 This risk declined substantially after 90 days post-splenectomy but remained higher 365 days postsplenectomy for all indications compared to the general population. 59 This may suggest that the indication for splenectomy is the determinant factor on outcome. The best prognosis being with splenectomy for trauma than for an associated disease process.
60
This is also in line with the observation that the ability of an asplenic individual to mount an adequate protective antibody response may relate more to the indication for, or age at, splenectomy, and to the presence of underlying immune suppression than the absence of the spleen. 61 With the largely significant success of prophylactic measures to prevent OPSI, other complications of asplenia are surfacing.
14e18, 65 The compelling evidence for a hypercoagulable state after splenectomy performed for various indications is probably compounded by other underlying conditions, especially intravascular haemolysis as seen in thalassaemia and sickle cell disease 14 Recent observations suggest that asplenia may be a risk factor for pulmonary hypertension irrespective of the underlying condition. 15 Although there is substantial evidence that pulmonary hypertension and venous thrombosis occur at increased rates in asplenic hosts, the strength of evidence is less convincing with atherothrombosis causing dementia, myocardial infarction and stroke. However, the observed memory disturbances due to ischaemic small vessel disease associated with platelet disorders following splenectomy warrants further investigation. 66 Thus, vascular events after splenectomy are likely to be multifactorial. It may result from some combination of hypercoagulability, platelet activation, disturbance and activation of the endothelium, and altered lipid profiles. 67 Absence of this extremely sensitive filter function of the spleen may permit particulate matter and damaged cells to persist in the blood stream, thereby perturbing and activating the vascular endothelium leading to a shift in vascular homeostasis toward enhanced coagulation. Unfortunately, despite these risks alongside the potential benefits no condition is actually cured by splenectomy. The spleen is however simply an enlarged lymph node.
Conclusions
The spleen, whether anatomically and physiologically normal or diseased, may significantly worsen the clinical picture in a variety of medical disorders. However, splenectomy should be undertaken only after careful balancing of the short and long term risks and potential benefits to the patient. Most of this risk seems to be due to the underlying splenectomy indication and not to splenectomy alone.
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